SAN DIEGO, Oct. 12, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced today that it will host an investor meeting on Thursday, October 13, 2011, from 7:30 am - 11:30 am ET in New York.
